loading
Precedente Chiudi:
$1.43
Aprire:
$1.38
Volume 24 ore:
282.21K
Relative Volume:
1.51
Capitalizzazione di mercato:
$43.36M
Reddito:
-
Utile/perdita netta:
$-21.24M
Rapporto P/E:
-1.6708
EPS:
-0.8379
Flusso di cassa netto:
$-22.47M
1 W Prestazione:
-33.96%
1M Prestazione:
-44.22%
6M Prestazione:
-60.89%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$1.26
$1.43
Intervallo di 1 settimana:
Value
$1.26
$2.25
Portata 52W:
Value
$1.26
$17.65

Skye Bioscience Inc Stock (SKYE) Company Profile

Name
Nome
Skye Bioscience Inc
Name
Telefono
(858) 410-0266
Name
Indirizzo
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
Name
Dipendente
16
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
SKYE's Discussions on Twitter

Confronta SKYE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
 icon
SKYE
Skye Bioscience Inc.
3.10 12.89M 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.64 372.90M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.1672 352.85M 2.07B -1.42B -1.37B -0.6765
 icon
MOBBW
Mobilicom Limited Warrants
0.34 278.60M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
11.05 144.42M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.20 137.80M 0 0 0 0.00

Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-28 Iniziato William Blair Outperform
2024-09-30 Iniziato Scotiabank Sector Outperform
2024-09-10 Iniziato JMP Securities Mkt Outperform
2024-07-09 Iniziato Craig Hallum Buy
2024-05-23 Iniziato Cantor Fitzgerald Overweight
2024-04-12 Iniziato Oppenheimer Outperform
Mostra tutto

Skye Bioscience Inc Borsa (SKYE) Ultime notizie

pulisher
Apr 02, 2025

Charles Schwab Investment Management Inc. Has $176,000 Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Charles Schwab Investment Management Inc. Grows Stock Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

10,142 Shares in Skye Bioscience, Inc. (NASDAQ:SKYE) Acquired by Virtu Financial LLC - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Invests $29,000 in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World

Apr 02, 2025
pulisher
Mar 30, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Consensus Rating of “Buy” from Analysts - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives $18.00 Average Price Target from Analysts - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Mar 28, 2025
pulisher
Mar 25, 2025

Skye Bioscience, Inc. (PNK:SKYE) Q4 2024 Earnings Call Transcript - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

Skye Bioscience (NASDAQ:SKYE) Receives Outperform Rating from William Blair - MarketBeat

Mar 25, 2025
pulisher
Mar 25, 2025

Skye Bioscience promotes Tu Diep to COO post - The Pharma Letter

Mar 25, 2025
pulisher
Mar 25, 2025

Craig Hallum Issues Pessimistic Forecast for Skye Bioscience (NASDAQ:SKYE) Stock Price - MarketBeat

Mar 25, 2025
pulisher
Mar 24, 2025

Skye Bioscience (NASDAQ:SKYE) Announces Quarterly Earnings Results - MarketBeat

Mar 24, 2025
pulisher
Mar 23, 2025

Skye Bioscience’s SWOT analysis: novel obesity drug stock faces pivotal year - Investing.com Canada

Mar 23, 2025
pulisher
Mar 23, 2025

Skye Bioscience’s (SKYE) “Outperform” Rating Reiterated at William Blair - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Skye Bioscience’s SWOT analysis: novel obesity drug stock faces pivotal year By Investing.com - Investing.com South Africa

Mar 22, 2025
pulisher
Mar 22, 2025

SKYE Stock Price and Chart — NASDAQ:SKYE - TradingView

Mar 22, 2025
pulisher
Mar 21, 2025

Skye Bioscience’s Positive Earnings Call Highlights Nimacimab Progress - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Skye Bioscience (SKYE) and Bristol-Myers Squibb (BMY) - The Globe and Mail

Mar 21, 2025
pulisher
Mar 21, 2025

Citizens JMP reiterates Skye Bioscience at market outperform By Investing.com - Investing.com Canada

Mar 21, 2025
pulisher
Mar 21, 2025

Citizens JMP reiterates Skye Bioscience at market outperform - Investing.com India

Mar 21, 2025
pulisher
Mar 21, 2025

Skye Bioscience (NASDAQ:SKYE) Shares Down 31% – Time to Sell? - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Skye Bioscience (NASDAQ:SKYE) Stock Price Down 31% – Time to Sell? - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Skye Bioscience Reports 2024 Financial Results and Trial Progress - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

Skye Bioscience accelerates nimacimab clinical trial timeline with early enrollment and extended treatment period - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

Earnings call transcript: Skye Bioscience Q4 2024 highlights financials, product progress - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience Inc. (SKYE) reports earnings - Quartz

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience Reports Fourth Quarter And Full Year 2024 Financial Results And Provides Business Update - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Skye's Obesity Drug Trial Hits Major Milestone with Strong Financial Backing - StockTitan

Mar 20, 2025
pulisher
Mar 18, 2025

Skye Bioscience Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView

Mar 18, 2025
pulisher
Mar 17, 2025

SKYE BIOSCIENCE Earnings Preview: Recent $SKYE Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 17, 2025
pulisher
Mar 14, 2025

Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025 - The Manila Times

Mar 14, 2025
pulisher
Mar 14, 2025

Skye Bioscience to Host Conference Call on March 20, 2025, to Discuss Q4 and Full-Year 2024 Financial Results - Nasdaq

Mar 14, 2025
pulisher
Mar 14, 2025

Skye Bioscience Q4 Earnings: Obesity Treatment Pioneer Reveals 2024 Financial Performance - StockTitan

Mar 14, 2025
pulisher
Mar 05, 2025

Brokerages Set Skye Bioscience, Inc. (NASDAQ:SKYE) Price Target at $18.67 - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Skye Bioscience, Inc. (NASDAQ:SKYE) Given Average Rating of "Buy" by Analysts - MarketBeat

Mar 04, 2025
pulisher
Mar 04, 2025

Skye Bioscience (NASDAQ:SKYE) Trading Down 2%Should You Sell? - MarketBeat

Mar 04, 2025
pulisher
Mar 04, 2025

Skye Bioscience (NASDAQ:SKYE) Coverage Initiated at William Blair - MarketBeat

Mar 04, 2025
pulisher
Mar 02, 2025

Skye Bioscience (NASDAQ:SKYE) Research Coverage Started at William Blair - Defense World

Mar 02, 2025

Skye Bioscience Inc Azioni (SKYE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):